Evaluating the Safety and Immunogenicity of MTBVAC

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

South Africa

Soweto - Gauteng, Johannesburg, Gauteng

Johannesburg - CHRU, Westdene, Gauteng

Durban - Botha's Hill CRS, Durban, KwaZulu-Natal

Durban - Wentworth, Durban, KwaZulu-Natal

Cape Town - UCTLI, Cape Town, Western Cape